Euan Ashley on the Functional Landscape of Coding Variation in the FH Gene LDLR
Euan Ashley, Chair at Stanford Department of Medicine, Author of The Genome Odyssey, shared on LinkedIn:
”So excited about this new work from our CardioVar consortium out this week in Science Magazine led by the amazing Daniel Tabet, and Fritz Roth.
Familial hypercholesterolemia (FH) is among the most common inherited cardiovascular diseases.
It causes early heart attacks that are preventable with modern therapy and a genomics-forward strategy for family testing.
The challenge is that many variants identified by sequencing are of unclear significance.
The new science of “variant effect mapping” uses cellular biology to model all possible variants in important genes in advance, providing scientists and clinicians with estimates as to their pathogenicity.
Here, Daniel and team tested the impact of nearly all possible (~17,000) missense coding variants in the receptor for LDL (“bad cholesterol”), the gene most commonly responsible for FH.
Importantly, they tested two functional readouts: LDLR cell-surface abundance and LDL uptake.
This yielded sequence–function maps that recapitulate known biochemistry, offer functional insights, and provide evidence for interpreting clinical variants.
Further, functional scores correlated with hyperlipidemia phenotypes in prospective human cohorts and augmented polygenic scores to improve risk inference.
These sorts of maps will increasingly become central tools in our quest to understand disease-causing human genes to help patients and prevent disease.
Amazing work from Daniel, Fritz and team.
Paper.
Variant effect map review.
Cardiovar consortium.
Atlas of variant effect maps.”
Read the full article in Science.
Article: The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR
Authors: Anna Axakova, Euan Ashley, Mafalda Bourbon, Jack M. P. Castelli, Melina Claussnitzer, Elizabeth T. Cirulli, Atina G. Coté, Carmela Serio Carrero, Da Kuang, Daniel R. Tabet, Douglas M. Fowler, Iosifina Fotiadou, Aanshi Gandhi, Michael Garton, Andrew M. Glazer, Robert A. Hegele, Mohammad Majharul Islam, Jennifer J. Knapp, Joshua W. Knowles, Brett M. Kroncke, Nishka Kishore, Roujia Li, Megan C. Lancaster, Calum A. MacRae, Kenneth Matreyek, Ranim Maaieh, Victoria N. Parikh, Simon G. Pfisterer, Ashyad Rayhan, Dan M. Roden, Frederick P. Roth, Shahin Sowlati-Hashjin, Olivia Taverniti, Jochen Weile.
Stay updated on all scientific advances with Hemostasis Today.
-
Dec 19, 2025, 13:30PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
-
Dec 19, 2025, 13:22If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
-
Dec 19, 2025, 12:52Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025